Results
1 -
10 of
42Christopher John A., Aves Sarah J., Brown Jason, Errey James C., Klair Suki S., Langmead Christopher J., Mace Oliver J., Mould Richard, Patel Jayesh C., Tehan Benjamin G., Zhukov Andrei, Marshall Fiona H., Congreve Miles.
Discovery of HTL6641, a dual orexin receptor antagonist with differentiated pharmacodynamic properties, Med. Chem. Commun., 2015 Role of hypocretin/orexin receptor blockade on drug-taking and ultrasonic vocalizations (USVs) associated with low-effort self-administration of cathinone-derived 3,4-methylenedioxypyrovalerone (MDPV) in rats, Psychopharmacology Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators, BMC Neuroscience Clinical Pharmacokinetics and Pharmacodynamics of Anxiolytics and Sedative/Hypnotics, Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents Orexin/Hypocretin Antagonists in Insomnia: From Bench to Clinic, Drug Treatment of Sleep Disorders Efficacy and tolerability of Z-drug adjunction to antidepressant treatment for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials, European Archives of Psychiatry and Clinical Neuroscience Selective Serotonin 5-HT2A Receptor Antagonists and Inverse Agonists Specifically Promote Slow Wave Sleep (Stage N3) in Man, Sleep and Vigilance Zolpidem, Reactions Weekly Pharmacological Treatment of Insomnia, Clinical Handbook of Insomnia